SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cadila Healthcare to consider unaudited financial results

16 Jan 2013 Evaluate

Cadila Healthcare has informed that a meeting of the board of directors of the company will be held on February 08, 2013, to consider unaudited financial results for the quarter/nine months ended on December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1169.75 16.85 (1.46%)
08-Jul-2026 12:41 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1893.50
Dr. Reddys Labs. 1360.25
Cipla 1455.75
Zydus Lifesciences 1169.75
Lupin 2491.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: